About Biomaxima SA 
Biomaxima SA
Pharmaceuticals & Biotechnology
BioMaxima SA is a Poland-based company active in the laboratory diagnostics sector. It manufactures and distributes reagents and equipment for the laboratory diagnosis. It produces reagents for the in vitro diagnosis. The main product groups offered by BioMaxima include: diagnostic reagents and analyzers for clinical biochemistry; rapid tests and readers for detecting infectious diseases, cancer markers, cardiac markers and drugs of abuse; urine analysis systems; hematology analyzers and reagents; ion-selective analyzers and reagents; reagents and immunological analyzers of cardiac markers; glucometers; analyzers for gasometric tests and critical blood parameters tests. The Company supplies hospitals and laboratories in Poland, as well as in Lithuania, Latvia, Romania and France. On March 20, 2014, the Company merged with its wholly owned subsidiary Cebo Sp z o o.
Company Coordinates 
Company Details
Ul. Vetterow 5 , LUBLIN None : 20-277
Registrar Details
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
Mr. Rafal Jelonek
Chairman of the Supervisory Board
Mr. Krzysztof Mikosz
Vice Chairman of the Supervisory Board
Mr. Michal Janik
Member of the Supervisory Board
Mr. Piotr Janowski
Member of the Supervisory Board
Mr. Kacper Krysiak
Member of the Supervisory Board
Mr. Tomasz Libera
Member of the Supervisory Board
Mr. Artur Wojcieszuk
Member of the Supervisory Board
Revenue and Profits:
Net Sales:
15 Million
(Quarterly Results - Mar 2025)
Net Profit:
1 Million
Pharmaceuticals & Biotechnology
PLN 48 Million (Micro Cap)
54.00
NA
0.00%
0.30
1.39%
1.02






